Year: 2020

news_6

Revelation Biosciences Inc. Receives TGA Acknowledgment to Start a Phase 1 Clinical Study of REVTx?99 an Experimental Treatment for COVID?19

MENLO PARK, Calif.--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences Inc. (Revelation), a clinical stage life sciences company focused on the development of immunologic-based therapies...